Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Herrstedt

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2015
Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-upD E Peterson, C B Boers-Doets, R J Bensadoun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
Dose-finding study of oral metopimazineJ Herrstedt, T Sigsgaard, H R Angelo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 22, 2023
MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines updateJ Herrstedt, R Clark-Snow, C H Ruhlmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 169 49AB Svenstrup, J Herrstedt, N Brünner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancerM Sorensen, P B Jensen, J Herrstedt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomitingJ Herrstedt, J Hannibal, J Hallas, et al.
ESMO Open|April 23, 2021
Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countriesA Molassiotis, S Tyrovolas, I Giné-Vázquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancerJ Herrstedt, T Sigsgaard, J Handberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
Non-intercepted dose errors in prescribing anti-neoplastic treatment: a prospective, comparative cohort studyT O Mattsson, B Holm, H Michelsen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The limited value of routine chest X-ray in the follow-up of stage II breast cancerV B Løgager, A Vestergaard, J Herrstedt, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2015
Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-upD E Peterson, C B Boers-Doets, R J Bensadoun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1997
Dose-finding study of oral metopimazineJ Herrstedt, T Sigsgaard, H R Angelo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 22, 2023
MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines updateJ Herrstedt, R Clark-Snow, C H Ruhlmann, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 169 49AB Svenstrup, J Herrstedt, N Brünner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancerM Sorensen, P B Jensen, J Herrstedt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1991
High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomitingJ Herrstedt, J Hannibal, J Hallas, et al.
ESMO Open|April 23, 2021
Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countriesA Molassiotis, S Tyrovolas, I Giné-Vázquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancerJ Herrstedt, T Sigsgaard, J Handberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
Non-intercepted dose errors in prescribing anti-neoplastic treatment: a prospective, comparative cohort studyT O Mattsson, B Holm, H Michelsen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
The limited value of routine chest X-ray in the follow-up of stage II breast cancerV B Løgager, A Vestergaard, J Herrstedt, et al.
Pageof 7